Novo Nordisk AS
A3EU6F
DK0062498333 //
Quelle: CPH Equities: 20.11.2026, 17:03:58
264,50 DKK
Kurs
Kurs
-0,25%
Diff. Vortag in %
Diff. Vortag in %
224,25 DKK
52 Wochen Tief
52 Wochen Tief
409,95 DKK
52 Wochen Hoch
52 Wochen Hoch
- Neutral
- Seit dem 25.09.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12.11.2026 0 Monate | 12.11.2026 | 0 Monate | 264,50 305 | 264,50 | 305 | 15,311909 | BERENBERG | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 264,50 240 | 264,50 | 240 | 9,26276 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 264,50 240 | 264,50 | 240 | 9,26276 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 05.11.2026 0 Monate | 05.11.2026 | 0 Monate | 264,50 223 | 264,50 | 223 | 15,689981 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 04.11.2026 0 Monate | 04.11.2026 | 0 Monate | 264,50 275 | 264,50 | 275 | 3,969754 | JEFFERIES | ||
| Novo Nordisk AS | 04.11.2026 0 Monate | 04.11.2026 | 0 Monate | 264,50 275 | 264,50 | 275 | 3,969754 | JPMORGAN | ||
| Novo Nordisk AS | 04.11.2026 12 Monate | 04.11.2026 | 12 Monate | 264,50 304 | 264,50 | 304 | 14,933837 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 04.11.2026 0 Monate | 04.11.2026 | 0 Monate | 264,50 312 | 264,50 | 312 | 17,958412 | UBS | ||
| Novo Nordisk AS | 28.10.2026 0 Monate | 28.10.2026 | 0 Monate | 264,50 275 | 264,50 | 275 | 3,969754 | JPMORGAN | ||
| Novo Nordisk AS | 14.10.2026 0 Monate | 14.10.2026 | 0 Monate | 264,50 332 | 264,50 | 332 | 25,519849 | UBS | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 264,50 225 | 264,50 | 225 | 14,933837 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 05.10.2026 0 Monate | 05.10.2026 | 0 Monate | 264,50 275 | 264,50 | 275 | 3,969754 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 12 Monate | 12 Monate | 264,50 245 | 264,50 | 245 | 7,372401 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 264,50 245 | 264,50 | 245 | 7,372401 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 22.09.2026 12 Monate | 22.09.2026 | 12 Monate | 264,50 305 | 264,50 | 305 | 15,311909 | BERENBERG | ||
| Novo Nordisk AS | 21.09.2026 12 Monate | 21.09.2026 | 12 Monate | 264,50 285 | 264,50 | 285 | 7,750473 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 21.09.2026 0 Monate | 21.09.2026 | 0 Monate | 264,50 275 | 264,50 | 275 | 3,969754 | JPMORGAN | ||
| Novo Nordisk AS | 21.09.2026 12 Monate | 21.09.2026 | 12 Monate | 264,50 275 | 264,50 | 275 | 3,969754 | JEFFERIES | ||
| Novo Nordisk AS | 21.09.2026 0 Monate | 21.09.2026 | 0 Monate | 264,50 260 | 264,50 | 260 | 1,701323 | JPMORGAN | ||
| Novo Nordisk AS | 21.09.2026 0 Monate | 21.09.2026 | 0 Monate | 264,50 332 | 264,50 | 332 | 25,519849 | UBS | ||
| Novo Nordisk AS | 16.09.2026 0 Monate | 16.09.2026 | 0 Monate | 264,50 332 | 264,50 | 332 | 25,519849 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 264,50 265 | 264,50 | 265 | 0,189036 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.09.2026 12 Monate | 11.09.2026 | 12 Monate | 264,50 250 | 264,50 | 250 | 5,482042 | MORGAN STANLEY | ||
| Novo Nordisk AS | 07.09.2026 12 Monate | 07.09.2026 | 12 Monate | 264,50 300 | 264,50 | 300 | 13,42155 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 03.09.2026 0 Monate | 03.09.2026 | 0 Monate | 264,50 275 | 264,50 | 275 | 3,969754 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 264,50 265 | 264,50 | 265 | 0,189036 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 264,50 265 | 264,50 | 265 | 0,189036 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 12 Monate | 12 Monate | 264,50 290 | 264,50 | 290 | 9,640832 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 24.08.2026 0 Monate | 24.08.2026 | 0 Monate | 264,50 275 | 264,50 | 275 | 3,969754 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 264,50 290 | 264,50 | 290 | 9,640832 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.08.2026 0 Monate | 11.08.2026 | 0 Monate | 264,50 305 | 264,50 | 305 | 15,311909 | BERENBERG | ||
| Novo Nordisk AS | 07.08.2026 0 Monate | 07.08.2026 | 0 Monate | 264,50 | 264,50 | -- | DZ BANK | |||
| Novo Nordisk AS | 06.08.2026 12 Monate | 06.08.2026 | 12 Monate | 264,50 285 | 264,50 | 285 | 7,750473 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.08.2026 12 Monate | 06.08.2026 | 12 Monate | 264,50 290 | 264,50 | 290 | 9,640832 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 05.08.2026 0 Monate | 05.08.2026 | 0 Monate | 264,50 200 | 264,50 | 200 | 24,385633 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 05.08.2026 0 Monate | 05.08.2026 | 0 Monate | 264,50 332 | 264,50 | 332 | 25,519849 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 05.08.2026 12 Monate | 05.08.2026 | 12 Monate | 264,50 310 | 264,50 | 310 | 17,202268 | BARCLAYS | ||
| Novo Nordisk AS | 04.08.2026 12 Monate | 04.08.2026 | 12 Monate | 264,50 285 | 264,50 | 285 | 7,750473 | JEFFERIES | ||
| Novo Nordisk AS | 04.08.2026 0 Monate | 04.08.2026 | 0 Monate | 264,50 332 | 264,50 | 332 | 25,519849 | UBS | ||
| Novo Nordisk AS | 31.07.2026 0 Monate | 31.07.2026 | 0 Monate | 264,50 250 | 264,50 | 250 | 5,482042 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 264,50 290 | 264,50 | 290 | 9,640832 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 10.07.2026 0 Monate | 10.07.2026 | 0 Monate | 264,50 332 | 264,50 | 332 | 25,519849 | UBS | ||
| Novo Nordisk AS | 29.06.2026 12 Monate | 29.06.2026 | 12 Monate | 264,50 285 | 264,50 | 285 | 7,750473 | JEFFERIES | ||
| Novo Nordisk AS | 28.06.2026 0 Monate | 28.06.2026 | 0 Monate | 264,50 250 | 264,50 | 250 | 5,482042 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 264,50 290 | 264,50 | 290 | 9,640832 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.06.2026 0 Monate | 16.06.2026 | 0 Monate | 264,50 325 | 264,50 | 325 | 22,873346 | BERENBERG | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 264,50 290 | 264,50 | 290 | 9,640832 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 264,50 250 | 264,50 | 250 | 5,482042 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 264,50 250 | 264,50 | 250 | 5,482042 | JPMORGAN | ||
| Novo Nordisk AS | 03.06.2026 12 Monate | 03.06.2026 | 12 Monate | 264,50 305 | 264,50 | 305 | 15,311909 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 29.05.2026 0 Monate | 29.05.2026 | 0 Monate | 264,50 270 | 264,50 | 270 | 2,079395 | JEFFERIES | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 264,50 290 | 264,50 | 290 | 9,640832 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 264,50 290 | 264,50 | 290 | 9,640832 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 18.05.2026 0 Monate | 18.05.2026 | 0 Monate | 264,50 300 | 264,50 | 300 | 13,42155 | BARCLAYS | ||
| Novo Nordisk AS | 12.05.2026 12 Monate | 12.05.2026 | 12 Monate | 264,50 270 | 264,50 | 270 | 2,079395 | JEFFERIES | ||
| Novo Nordisk AS | 11.05.2026 12 Monate | 11.05.2026 | 12 Monate | 264,50 175 | 264,50 | 175 | 33,837429 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 264,50 290 | 264,50 | 290 | 9,640832 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 264,50 290 | 264,50 | 290 | 9,640832 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 264,50 | 264,50 | -- | DZ BANK | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 264,50 300 | 264,50 | 300 | 13,42155 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 264,50 332 | 264,50 | 332 | 25,519849 | UBS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 264,50 250 | 264,50 | 250 | 5,482042 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 12 Monate | 06.05.2026 | 12 Monate | 264,50 263 | 264,50 | 263 | 0,567108 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 264,50 250 | 264,50 | 250 | 5,482042 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 264,50 175 | 264,50 | 175 | 33,837429 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 264,50 300 | 264,50 | 300 | 13,42155 | BARCLAYS | ||
| Novo Nordisk AS | 29.04.2026 12 Monate | 29.04.2026 | 12 Monate | 264,50 250 | 264,50 | 250 | 5,482042 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 264,50 275 | 264,50 | 275 | 3,969754 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 264,50 270 | 264,50 | 270 | 2,079395 | JEFFERIES | ||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 264,50 250 | 264,50 | 250 | 5,482042 | JPMORGAN | ||
| Novo Nordisk AS | 15.04.2026 12 Monate | 15.04.2026 | 12 Monate | 264,50 270 | 264,50 | 270 | 2,079395 | JEFFERIES | ||
| Novo Nordisk AS | 09.04.2026 0 Monate | 09.04.2026 | 0 Monate | 264,50 332 | 264,50 | 332 | 25,519849 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 01.04.2026 0 Monate | 01.04.2026 | 0 Monate | 264,50 270 | 264,50 | 270 | 2,079395 | BARCLAYS | ||
| Novo Nordisk AS | 31.03.2026 12 Monate | 31.03.2026 | 12 Monate | 264,50 263 | 264,50 | 263 | 0,567108 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 30.03.2026 0 Monate | 30.03.2026 | 0 Monate | 264,50 270 | 264,50 | 270 | 2,079395 | BARCLAYS | ||
| Novo Nordisk AS | 29.03.2026 0 Monate | 29.03.2026 | 0 Monate | 264,50 250 | 264,50 | 250 | 5,482042 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 264,50 275 | 264,50 | 275 | 3,969754 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.03.2026 0 Monate | 26.03.2026 | 0 Monate | 264,50 270 | 264,50 | 270 | 2,079395 | BARCLAYS | ||
| Novo Nordisk AS | 25.03.2026 0 Monate | 25.03.2026 | 0 Monate | 264,50 250 | 264,50 | 250 | 5,482042 | JPMORGAN | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 264,50 270 | 264,50 | 270 | 2,079395 | JEFFERIES | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 264,50 270 | 264,50 | 270 | 2,079395 | BARCLAYS | ||
| Novo Nordisk AS | 11.03.2026 0 Monate | 11.03.2026 | 0 Monate | 264,50 300 | 264,50 | 300 | 13,42155 | BERENBERG | ||
| Novo Nordisk AS | 09.03.2026 0 Monate | 09.03.2026 | 0 Monate | 264,50 250 | 264,50 | 250 | 5,482042 | JPMORGAN | ||
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 264,50 270 | 264,50 | 270 | 2,079395 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 264,50 260 | 264,50 | 260 | 1,701323 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 264,50 270 | 264,50 | 270 | 2,079395 | BARCLAYS | ||
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 264,50 270 | 264,50 | 270 | 2,079395 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 264,50 400 | 264,50 | 400 | 51,228733 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 264,50 250 | 264,50 | 250 | 5,482042 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 264,50 400 | 264,50 | 400 | 51,228733 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 264,50 332 | 264,50 | 332 | 25,519849 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 264,50 340 | 264,50 | 340 | 28,544423 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 264,50 275 | 264,50 | 275 | 3,969754 | JEFFERIES | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 264,50 350 | 264,50 | 350 | 32,325142 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 264,50 340 | 264,50 | 340 | 28,544423 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 264,50 275 | 264,50 | 275 | 3,969754 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 264,50 250 | 264,50 | 250 | 5,482042 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 264,50 270 | 264,50 | 270 | 2,079395 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 264,50 340 | 264,50 | 340 | 28,544423 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 264,50 340 | 264,50 | 340 | 28,544423 | BARCLAYS |
News
Aktuell
Anlage-Spezial Europäische Aktien
28.05.2026
Novo Nordisk: KI und Amycretin zünden nächste Pipeline-Stufe
KI beschleunigt die Wirkstoffforschung von Novo Nordisk erheblich. Neue Tabletten wie Amycretin sichern dabei die künftige Marktdominanz ab.
DZ BANK Produktauswahl
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Min
Discount in %
Max
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Optionsscheine Classic Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M